ANI Pharmaceuticals (ANIP)

[Just the facts maam]

I though about Yescarta, as well. Hard to believe they can walk away from milestone payments and royalties.

CG Oncology obtained a patent for "Methods Of Treating Bladder Cancer By Combination Therapy Comprising The Oncolytic Adenovirus CG0070 And An Immune Checkpoint Inhibitor" which expires 2037-03-09,

https://patents.google.com/patent/US11497781B2/ja

Which I am certain ANIP could make a claim on some portion of prior art. This could delay any FDA approval, as the matter would likely need to be resolved before they receive a final approval. This could get them to abide by the initial agreement or force them to settle out.

It would also gum up any potential buyout. Unless of course, the buyout or partner to CG oncology is also partnering with ANIP on testosterone and makes it worth their while to step down.

Just spit-balling scenarios.